Although the study from Kieffer et al. focused on breast cancer, their findings clearly raise the question of whether the targeting of specific clusters of αSMA-positive fibroblasts could indeed be beneficial for patients to elicit an efficient T-cell mediated immunity against malignant cells. Here, ACTA1 is linked to breast carcinoma.